Virax Biolabs Group Ltd
VRAX0.830USD
-0.015-1.79%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
3.60MMarket Cap
--P/E TTM
Virax Biolabs Group Ltd
0.830
-0.015-1.79%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
46.62%-1.92M
-48.11%-2.79M
-56.50%-3.59M
---1.88M
---2.30M
Net income from continuing operations
5.41%-2.76M
4.47%-3.82M
-100.46%-2.91M
---4.00M
---1.45M
Operating gains losses
792.78%158.19K
--475.74K
--17.72K
----
----
Other non-cash items
177.06%52.45K
159.39%174.77K
---68.06K
---294.27K
----
Change in working capital
178.71%568.36K
-158.75%-534.21K
33.85%-722.11K
--909.36K
---1.09M
-Change in receivables
204.54%191.69K
---34.48K
---183.36K
----
----
-Change in inventory
-164.70%-64.87K
---35.88K
-216.98%-24.51K
--0.00
--20.95K
-Change in prepaid expenses
77.76%-83.15K
-67.76%142.64K
47.91%-373.95K
--442.39K
---717.87K
-Change in payables and accrued expense
713.01%301.97K
-223.34%-522.99K
87.37%-49.26K
--424.02K
---390.08K
-Change in other current assets
----
----
----
--4.69K
---4.69K
-Change in other current liabilities
220.72%222.73K
-73.98%9.95K
---184.50K
--38.25K
----
Cash from non-recurring investing activities
Cash from operating activities
46.62%-1.92M
-48.11%-2.79M
-56.50%-3.59M
---1.88M
---2.30M
Investing cash flow
Net cash from continuing investing activities
-64.98%248.00K
155.75%456.27K
--708.18K
--178.40K
----
Capital expenditures
-64.98%248.00K
166.59%475.61K
--708.18K
--178.40K
----
Net cash flow from disposal of fixed assets
-49.65%248.00K
--459.92K
--492.58K
----
----
Net cash flow from intangible asset transactions
-100.00%0.00
-102.05%-3.65K
--215.60K
--178.40K
----
Cash from non-current investing activities
Net cash flow from investing activities
64.98%-248.00K
-155.75%-456.27K
---708.18K
---178.40K
----
Financing cash flow
Cash flow from continuous financing activities
10099.64%5.86M
-74.77%1.73M
-99.16%57.49K
--6.84M
--6.84M
Net cash flow from debt Issuance/repayment
-418.04%-51.55K
75.38%-60.02K
-102.55%-9.95K
---243.75K
--390.00K
Net cash flow from common stock issuance/repurchase
2191432.48%5.13M
-100.00%0.00
-100.00%234.00
--7.10M
--6.56M
Proceeds from issuance of warrants
--786.74K
--1.87M
--0.00
----
----
Net cash flow from other financing activities
-100.00%0.00
-855.63%-85.50K
165.44%67.20K
---8.95K
---102.70K
Net cash from non-recurrent financing activities
Net cash from financing activities
10099.64%5.86M
-74.77%1.73M
-99.16%57.49K
--6.84M
--6.84M
Net cash flow
Beginning cash balance
-61.62%3.59M
11.77%5.11M
42888.32%9.35M
--4.57M
--21.76K
Current period cash flow changes
187.09%3.70M
-131.75%-1.52M
-193.32%-4.24M
--4.78M
--4.55M
Ending cash balance
42.64%7.29M
-61.62%3.59M
11.77%5.11M
--9.35M
--4.57M
Free cash flow
49.64%-2.17M
-58.36%-3.26M
---4.30M
---2.06M
----
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
